{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:07:53Z","timestamp":1648818473052},"reference-count":15,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2019,11,30]]},"DOI":"10.5582\/irdr.2019.01118","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T17:03:51Z","timestamp":1578762231000},"page":"279-282","source":"Crossref","is-referenced-by-count":1,"title":["Anaplastic glioneuronal tumor with &lt;i&gt;KIAA1549\/BRAF&lt;\/i&gt; fusion"],"prefix":"10.5582","volume":"8","author":[{"given":"Liqiong","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA."},{"name":"Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithvi","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA."},{"name":"University of California, Berkeley, Berkeley, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggang","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A. WHO Classification of Tumours of the Central Nervous System (4th edition) - Lyons: IARC Publications; 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bidinotto LT, Scapulatempo-Neto C, Mackay A, de Almeida GC, Scheithauer BW, Berardinelli GN, Torrieri R, Clara CA, Feltrin LT, Viana-Pereira M, Varella-Garcia M, Jones C, Reis RM. Molecular profiling of a rare rosette-forming glioneuronal tumor arising in the spinal cord. PLoS One. 2015; 10: e0137690.","DOI":"10.1371\/journal.pone.0137690"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pages M, Lacroix L, Tauziede-Espariat A, <i>et al<\/i>. Papillary glioneuronal tumors: Histological and molecular characteristics and diagnostic value of <i>SLC44A1-PRKCA <\/i>fusion. Acta Neuropathol Commun. 2015; 15:3:85.","DOI":"10.1186\/s40478-015-0264-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nikiforova MN, Wald AI, Melan MA, Roy S, Zhong S, Hamilton RL, Lieberman FS, Drappatz J, Amankulor NM, Pollack IF, Nikiforov YE, Horbinski C. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro Oncol. 2016; 18:379-387.","DOI":"10.1093\/neuonc\/nov289"},{"key":"5","unstructured":"5. Maraka S, Janku F. BRAF alterations in primary brain tumors. Discov Med. 2018; 26: 51-60."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549: BRAF fusion variants. J Neuropathol Exp Neurol. 2012; 71: 66-72.","DOI":"10.1097\/NEN.0b013e31823f2cb0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R; Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004; 116:855-867.","DOI":"10.1016\/S0092-8674(04)00215-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W. Raf family kinases: Old dogs have learned new tricks. Genes Cancer. 2011; 2:232-260.","DOI":"10.1177\/1947601911407323"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jones DT, Kocialkowski S, Liu L, Pearson DM, B\u00e4cklund LM, Ichimura K, Collins VP. Tandem duplication producing a novel oncogenic <i>BRAF<\/i> fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008; 68:8673-8677.","DOI":"10.1158\/0008-5472.CAN-08-2097"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Horbinski C, Nikiforova MN, Hagenkord JM, Hamilton RL, Pollack IF. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Neuro Oncol. 2012; 14:777-789.","DOI":"10.1093\/neuonc\/nos077"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Johnson A, Severson E, Gay L, <i>et al<\/i>. Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist. 2017; 22:1478-1490.","DOI":"10.1634\/theoncologist.2017-0242"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yang RR, Aibaidula A, Wang WW, <i>et al<\/i>. Pediatric low-grade gliomas can be molecularly stratified for risk. Acta Neuropathol. 2018; 136:641-655.","DOI":"10.1007\/s00401-018-1874-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, Liu L, B\u00e4cklund LM, Ichimura K, Collins VP. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol. 2011; 121:753-761.","DOI":"10.1007\/s00401-011-0810-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cruz GR, Dias Oliveira I, Moraes L, Del Giudice Paniago M, de Seixas Alves MT, Capellano AM, Saba-Silva N, Cavalheiro S, Cerutti JM, Toledo SR. Analysis of <i>KIAA1549\u2013BRAF<\/i> fusion gene expression and IDH1\/IDH2 mutations in low grade pediatric astrocytomas. J Neurooncol. 2014; 117:235-242.","DOI":"10.1007\/s11060-014-1398-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sievert AJ, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC. Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proc Natl Acad Sci USA. 2013; 110:5957-5962.","DOI":"10.1073\/pnas.1219232110"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/4\/8_2019.01118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T22:35:47Z","timestamp":1579300547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/4\/8_2019.01118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2019.01118","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}